JMS News

JMS: 1st quarter financial results SMS for the March 2025 period based on Japanese standards (consolidated).

Aug 9 14:00

JMS: Overview of Q1 2025 earnings report.

Aug 9 14:00

JMS: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.

Jul 17 14:00

JMS: Corporate Governance Report June 26, 2024

Jun 26 14:26

JMS: Interim report

Jun 26 10:22

JMS: Internal Control Report - 59th Term (2023/04/01 - 2024/03/31)

Jun 26 10:10

JMS: Confirmation letter

Jun 26 10:05

JMS: Financial Report - 59th Term (2023/04/01 - 2024/03/31)

Jun 26 09:55

JMS: Announcements of individual stocks regarding the exclusive sales and cooperation agreement with Terumo Shanghai.

Jun 5 10:00

JMS: Notification of the regular shareholders' meeting in 2024.

Jun 4 07:00

JMS: Notice of Regular Shareholders' Meeting Convened in 2024 and Shareholders' Meeting Materials.

Jun 4 07:00

JMS: Teijin Pharma and JMS signed an agreement to establish a joint venture focusing on peritoneal dialysis

May 20 10:00

JMS: Notice regarding the formulation of a medium-term management plan

May 14 14:00

JMS: 2024 financial results overview

May 14 14:00

JMS: Notice regarding the change of representative director

May 14 14:00

JMS: Notice regarding differences between full-year consolidated earnings forecasts and actual results

May 14 14:00

JMS: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

May 14 14:00

JMS: Notice regarding personnel changes

Mar 26 14:00

JMS: Confirmation

Feb 13 09:51

JMS: Quarterly Report - 59th Quarter 3 (2023/10/01 to 2023/12/31)

Feb 13 09:46